Eskayef Pharmaceuticals Limited, a premier pharmaceutical company based in Bangladesh, began its journey in 1990 when the Bangladesh operations of SK&F, USA were acquired by the Transcom Group. Over the past 31 years, Eskayef has become synonymous with premium quality, offering world-class medicines both locally and internationally. The company specializes in various therapeutic areas, notably oncology, where it provides innovative treatments aimed at enhancing the lives of cancer patients. Eskayef's extensive product range also includes formulations for diverse health needs and animal health solutions.

Dedicated to ethical practices and continuous improvement, Eskayef operates with state-of-the-art facilities and a strong commitment to research and development. With an international footprint that spans over 70 countries, the company is known for its adherence to high global quality standards, evidenced by multiple GMP accreditations. Eskayef Pharmaceuticals is not only focused on commercial success but also on its mission to serve humanity by ensuring superior, affordable, and effective medicines for all.